Phong Phu Pharmaceutical JSC (HNX:PPP)
Vietnam
· Delayed Price · Currency is VND 20,200
+700 (3.59%)
At close: Mar 6, 2026
HNX:PPP Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 139,831 | 137,548 | 152,172 | 150,575 | 133,289 | Upgrade
|
| Revenue Growth (YoY) | 1.66% | -9.61% | 1.06% | 12.97% | 14.65% | Upgrade
|
| Cost of Revenue | 90,502 | 91,144 | 103,016 | 99,285 | 88,053 | Upgrade
|
| Gross Profit | 49,329 | 46,404 | 49,156 | 51,290 | 45,237 | Upgrade
|
| Selling, General & Admin | 28,129 | 26,149 | 26,046 | 26,096 | 25,543 | Upgrade
|
| Operating Expenses | 28,129 | 26,149 | 26,046 | 26,096 | 25,543 | Upgrade
|
| Operating Income | 21,200 | 20,255 | 23,110 | 25,194 | 19,693 | Upgrade
|
| Interest Expense | -85.17 | - | - | -45.36 | -434.42 | Upgrade
|
| Interest & Investment Income | 1,719 | 1,390 | 1,327 | 561.01 | 109.53 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.96 | -1.46 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 362.89 | 143.82 | 150.99 | 93.21 | 77.97 | Upgrade
|
| EBT Excluding Unusual Items | 23,197 | 21,788 | 24,587 | 25,802 | 19,446 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 22.35 | 0.94 | - | - | Upgrade
|
| Pretax Income | 23,197 | 21,810 | 24,588 | 25,802 | 19,446 | Upgrade
|
| Income Tax Expense | 4,642 | 4,451 | 4,486 | 5,191 | 2,553 | Upgrade
|
| Net Income | 18,555 | 17,359 | 20,102 | 20,611 | 16,893 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 1,812 | 1,964 | - | - | Upgrade
|
| Net Income to Common | 18,555 | 15,548 | 18,138 | 20,611 | 16,893 | Upgrade
|
| Net Income Growth | 6.89% | -13.64% | -2.47% | 22.01% | 72.11% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 9 | 9 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 9 | 9 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 11.92% | - | -9.83% | -0.34% | -0.72% | Upgrade
|
| EPS (Basic) | 1884.00 | 1766.77 | 2061.13 | 2112.00 | 1725.00 | Upgrade
|
| EPS (Diluted) | 1884.00 | 1766.77 | 2061.13 | 2112.00 | 1725.00 | Upgrade
|
| EPS Growth | 6.64% | -14.28% | -2.41% | 22.43% | 73.37% | Upgrade
|
| Free Cash Flow | 15,273 | 16,787 | 17,428 | 20,117 | 18,129 | Upgrade
|
| Free Cash Flow Per Share | 1550.73 | 1907.56 | 1980.47 | 2061.38 | 1851.27 | Upgrade
|
| Dividend Per Share | - | 1500.000 | 1200.000 | 1400.000 | - | Upgrade
|
| Dividend Growth | - | 25.00% | -14.29% | - | - | Upgrade
|
| Gross Margin | 35.28% | 33.74% | 32.30% | 34.06% | 33.94% | Upgrade
|
| Operating Margin | 15.16% | 14.73% | 15.19% | 16.73% | 14.77% | Upgrade
|
| Profit Margin | 13.27% | 11.30% | 11.92% | 13.69% | 12.67% | Upgrade
|
| Free Cash Flow Margin | 10.92% | 12.20% | 11.45% | 13.36% | 13.60% | Upgrade
|
| EBITDA | 25,336 | 24,368 | 27,926 | 31,419 | 25,871 | Upgrade
|
| EBITDA Margin | 18.12% | 17.72% | 18.35% | 20.87% | 19.41% | Upgrade
|
| D&A For EBITDA | 4,136 | 4,112 | 4,816 | 6,225 | 6,178 | Upgrade
|
| EBIT | 21,200 | 20,255 | 23,110 | 25,194 | 19,693 | Upgrade
|
| EBIT Margin | 15.16% | 14.73% | 15.19% | 16.73% | 14.77% | Upgrade
|
| Effective Tax Rate | 20.01% | 20.41% | 18.25% | 20.12% | 13.13% | Upgrade
|
| Revenue as Reported | 139,831 | 137,548 | 152,172 | 150,575 | 133,289 | Upgrade
|
| Advertising Expenses | - | 490.39 | 285.73 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.